Search Results - Biopharmaceutical

3 Results Sort By:
Muscarinic Agonists for the Treatment of Autism Spectrum Disorder
Project ID: D2011-54Background Autism Spectrum Disorder (ASD) describes a group of developmental disorders that is often characterized by persistent repetitive and restrictive behaviors and deficits in social communication that, overall, affect the ability of the individual to functional normally in a social setting. Although early treatment and ...
Generation of Stable iTregs as Therapeutics against Autoimmune Diseases (Type I Diabetes)
Project ID: D2010-30 Invention novelty: New methods for induction and expansion of stable iTregs without addition of exogenous TGF-βValue Proposition: The “anti-self” immune response in human body leads to development of autoimmune diseases. For example, Diabetes mellitus type 1 (formerly known as juvenile diabetes) results from au...
Engineered Protein Tames Bleeding In Haemophiliacs and Targets Angiogenesis in Cancer
Project ID: D2007-12 U.S. Patent #8,211,858; Canada, European patents pending U.S. Patent #7,592,422; Canada, France, Germany, Netherlands, UK patents pending Novelty: Modified plasminogen activator inhibitor type I (PAI- 1) with significantly increased in vivo half-life and decreased activity to urokinase plasminogen activator, tissue plasminog...